Table 2 Univariate analysis of factors associated with OS and PFS in 168 glioma patients
From: Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
Factors | OS | PFS | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (< 60 vs. ≥60) | 2.217 (1.229–3.998) | 0.008 | 2.281 (1.409–3.692) | 0.001 |
Gender (Male vs. female) | 0.669 (0.379–1.181) | 0.166 | 0.719 (0.465–1.113) | 0.139 |
WHO grade (I-II vs. III-IV) | 10.095 (5.481–18.582) | 0.000 | 5.806 (3.784–8.908) | 0.000 |
Ki-67 index (< 20% vs. ≥20%) | 2.262 (1.312-3.900) | 0.003 | 2.061 (1.353–3.137) | 0.001 |
MYH9 expression (Low vs. high) | 2.265 (1.304–3.933) | 0.004 | 1.621 (1.069–2.458) | 0.023 |